Strains
Bifidobacterium lactis
NOVI-22
A Bifidobacteria strain researched in infants, children and adults, with proven health benefits across various areas and functions. It has been shown to reach the gut alive through confirmed microbial changes in the stools and fecal recovery.
Health Benefits of NOVI-22:
Adult Digestive & Immune
- Digestive health support
- Improves GI health
- Improves regularity
- Supports immune health
- Improves immune function
Children’s Health
- May reduce respiratory tract infections
- Supports immune health
- Supports digestive health
Infant’s Health
- Improves symptoms of eczema
- Colic support/reduction
- Supports respiratory health
- Immune support
- Fewer episodes of diarrhea
Clinical Dosage for NOVI-22:
Adult Digestive & Immune: 10 billion CFU per day
Children’s Health: 10 billion CFU per day
Infant’s Health: 1 billion CFU per day